Skip to the page

Data / Drug companies / Xttrium Laboratories, Inc.

Xttrium Laboratories, Inc.: 44 products in the FDA NDC directory, labeler code 0116

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Xttrium Laboratories, Inc. (labeler code 0116) lists 44 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 22 over the counter drugs, 21 prescription drugs. Its main marketing category is new drug applications (NDA). The newest product started marketing on September 22, 2026.

The request: Watch Xttrium Laboratories, Inc. (FDA labeler code 0116): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0116
Products in commercial distribution
44
Packages
86
Finished drugs by generic name
13
Prescription products
21
Over the counter products
22
Flagged as original packager
42 of 42 products that carry the flag
Started marketing in the last 12 months
2
Products with a marketing end date set
11
Earliest marketing start
November 18, 1982
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
New drug applications (NDA)2454.5%
Generic drugs (ANDA)1943.2%
Bulk ingredients12.3%

Products by type

TypeProductsShare
Over the counter drugs2250%
Prescription drugs2147.7%
Bulk ingredients12.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Solution1943.2%
Liquid1534.1%
Rinse613.6%
Syrup24.5%
Suspension24.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Chlorhexidine Gluconate0116-1999RinseGeneric drugs (ANDA)September 22, 2026
Nystatin Oral Suspension0116-4026SuspensionGeneric drugs (ANDA)February 6, 2026
Promethazine Hydrochloride and Dextromethorphan Hydrobromide0116-4024SyrupGeneric drugs (ANDA)April 7, 2025
Promethazine hydrochloride0116-4023SyrupGeneric drugs (ANDA)April 7, 2025
Megestrol Acetate0116-4011SuspensionGeneric drugs (ANDA)March 28, 2025
Amantadine0116-4010SolutionGeneric drugs (ANDA)November 5, 2024
Dyna-Hex 20116-1022SolutionNew drug applications (NDA)December 14, 2023
Dyna-Hex 40116-1060LiquidNew drug applications (NDA)November 15, 2023
Foster and Thrive0116-1221SolutionNew drug applications (NDA)October 27, 2023
Lidocaine hydrochloride0116-4027SolutionGeneric drugs (ANDA)March 28, 2023
CliniClean0116-0901SolutionNew drug applications (NDA)March 23, 2023
Bactoshield CHG0116-0039SolutionNew drug applications (NDA)November 22, 2022
Bactoshield CHG0116-0039SolutionNew drug applications (NDA)November 21, 2022
Bactoshield CHG0116-0038SolutionNew drug applications (NDA)November 16, 2022
Lactulose0116-4005SolutionGeneric drugs (ANDA)July 1, 2022
Antiseptic skin cleanser0116-1061SolutionNew drug applications (NDA)August 1, 2018
NUPRO Chlorhexidine Gluconate0116-0800RinseGeneric drugs (ANDA)January 17, 2017
Provon Antimicrobial Foam Handwash0116-8500SolutionNew drug applications (NDA)July 1, 2016
Dyna-Hex 20116-1022SolutionNew drug applications (NDA)January 29, 2016
Chlorhexidine Gluconate0116-0101LiquidGeneric drugs (ANDA)January 22, 2016
Dyna-hex 40116-1060LiquidNew drug applications (NDA)January 1, 2016
Cardinal Health0116-0061LiquidNew drug applications (NDA)July 24, 2015
Chlorhexidine Gluconate 0.12% Oral Rinse0116-0003LiquidGeneric drugs (ANDA)January 20, 2014
Dyna-hex 20116-1021LiquidNew drug applications (NDA)January 1, 2014
Dyna-hex 20116-1021LiquidNew drug applications (NDA)January 1, 2014

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.